Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
British Journal of Clinical Pharmacology|August 1, 1995
Respiratory depression following morphine and morphine-6-glucuronide in normal subjectsP I Thompson, S P Joel, L John, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusionV J Harvey, M L Slevin, G W Aherne, et al.
British Journal of Pharmacology|May 1, 1992
Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferretP I Thompson, S Bingham, P L Andrews, et al.
Acta Clinica Belgica|January 1, 1989
Autoimmune haemolytic anaemia associated with malignant peritoneal mesotheliomaD L Selleslag, R J Geraghty, T S Ganesan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1983
Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluidM L Slevin, E M Piall, G W Aherne, et al.
Clinical Pharmacology and Therapeutics|February 17, 2001
Randomized placebo-controlled trial of the activity of the morphine glucuronidesR T Penson, S P Joel, K Bakhshi, et al.
BMJ (Clinical Research Ed.)|September 10, 1988
BACUP--the first two years: evaluation of a national cancer information serviceM L Slevin, Y Terry, N Hallett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
Variable bioavailability following repeated oral doses of etoposideV J Harvey, M L Slevin, S P Joel, et al.
Pageof 13